Adagene Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Great. Good afternoon, everybody, and thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Very pleased to have Adagene with us for the next session.
Before we get started, I need to read a quick disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at morganstanley.com/research disclosure.
So with that, pleased to introduce Peter Luo, the CEO of Adagene. And Peter, I know you want to make some opening comments, so I'll turn it over to you for that. And then we can get into Q&A.
Thanks, Matthew. And thanks, everyone, for your time. And today, I'd like to take this opportunity to walk you through a few highlights about Adagene.
And here the investment highlights, I'd like to walk you
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
